T 0980/19 of 27.04.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T098019.20220427
- Date of decision
- 27 April 2022
- Case number
- T 0980/19
- Petition for review of
- -
- Application number
- 10006835.2
- IPC class
- C07K 5/08C07C 7/00C07F 5/02A61P 35/00C07F 5/04C07K 5/06A61P 29/00A61K 38/05C07K 7/02A61K 38/00C07K 5/078A61K 31/69
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- T 0980/19 2021-10-19
- Abstracts for this decision
- -
- Application title
- FORMULATION OF BORONIC ACID COMPOUNDS
- Applicant name
- THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Opponent name
- HGF Limited
Pfizer Inc.
Accord Healthcare Ltd
LEK Pharmaceuticals d.d.
Synthon B.V.
Fresenius Kabi Deutschland GmbH
Pentafarma Sociedade Técnico-Medicinal S.A.
Generics (U.K.) Limited
Teva Pharmaceuticals Inc. - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 124(1)
- Keywords
- Minutes of oral proceedings - request to correct minutes
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The request of opponent 9 for correction of the minutes of oral proceedings held on 18 and 19 October 2021 is refused.